Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27816182 | 0.91 | GPR84 (0.48) | PRKCAPRKCDGPR84FFAR1MAPT | |
| SCHEMBL29924279 | 0.89 | GPR84 (0.46) | PRKCAPRKCDGPR84FFAR1ZDHHC7 | |
| SCHEMBL28687233 | 0.89 | GPR84 (0.46) | PRKCAPRKCDGPR84FFAR1ZDHHC7 | |
| SCHEMBL17219357 | 0.89 | GPR84 (0.47) | PRKCAPRKCDGPR84FFAR1MAPT | |
| SCHEMBL93352 | 0.88 | GPR84 (0.53) | GPR84FFAR1ZDHHC7 | |
| SCHEMBL28704394 | 0.88 | GPR84 (0.48) | PRKCAPRKCDGPR84FFAR1ZDHHC7 | |
| SCHEMBL2890897 | 0.84 | PRKCA (0.43) | PRKCAPRKCDGPR84FFAR1LMNA | |
| SCHEMBL25182618 | 0.83 | GPR84 (0.50) | PRKCAPRKCDGPR84FFAR1MAPT | |
| SCHEMBL669156 | 0.82 | CA1 (0.46) | PRKCAPRKCDGPR84FFAR1MAPT | |
| SCHEMBL29682914 | 0.82 | CA1 (0.46) | PRKCAPRKCDGPR84FFAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514800-B2 | Personal and home care compositions comprising fatty acids from tung seed oil as antimicrobial preservative | GALAXY SURFACTANTS LTD. (IN) | 2026-01-06 | — | — | US | claimed |
| CN-113811364-B | Hair treatment method | 花王株式会社 | 2023-09-05 | — | — | CN | claimed |
| CN-110198702-B | Hair treatment method | 花王株式会社 | 2022-11-29 | — | — | CN | claimed |
| EP-4023237-A1 | PERSONAL AND HOME CARE COMPOSITIONS COMPRISING FATTY ACIDS FROM TUNG SEED OIL AS ANTIMICROBIAL PRESERVATIVE | Galaxy Surfactants Ltd. (IN) | 2022-07-06 | — | — | EP | claimed |
| US-20220202670-A1 | PERSONAL AND HOME CARE COMPOSITIONS COMPRISING FATTY ACIDS FROM TUNG SEED OIL AS ANTIMICROBIAL PRESERVATIVE | GALAXY SURFACTANTS LTD. (IN) | 2022-06-30 | — | — | US | claimed |
| US-20210322289-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | Schülke & Mayr GmbH (DE) | 2021-10-21 | — | — | US | claimed |
| EP-3849501-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | SCHÜLKE & MAYR GmbH (DE) | 2021-07-21 | — | — | EP | claimed |
| US-10603258-B2 | Cleansing composition | KAO GERMANY GMBH (DE) | 2020-03-31 | — | — | US | claimed |
| WO-2020043372-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | Schülke & Mayr GmbH (DE) | 2020-03-05 | — | — | WO | claimed |
| EP-2320863-B1 | CLEANSING COMPOSITION | KAO GERMANY GMBH (DE) | 2018-05-16 | — | — | EP | claimed |
| EP-2320855-A1 | CONDITIONING COMPOSITION FOR HAIR | KPSS-Kao Professional Salon Services GmbH (DE) | 2011-05-18 | — | — | EP | claimed |
| EP-2320856-A1 | CONDITIONING COMPOSITION FOR HAIR | KPSS-Kao Professional Salon Services GmbH (DE) | 2011-05-18 | — | — | EP | claimed |
| WO-2010025897-A1 | CONDITIONING COMPOSITION FOR HAIR | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2010-03-11 | — | — | WO | claimed |
| WO-2010025896-A1 | CONDITIONING COMPOSITION FOR HAIR | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2010-03-11 | — | — | WO | claimed |
| WO-2010025895-A1 | CLEANSING COMPOSITION | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2010-03-11 | — | — | WO | claimed |
| WO-2010025898-A1 | CLEANSING COMPOSITION | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2010-03-11 | — | — | WO | claimed |
| EP-2161014-A1 | Conditioning composition for hair | KPSS-Kao Professional Salon Services GmbH (DE) | 2010-03-10 | — | — | EP | claimed |
| EP-2161017-A1 | Cleansing composition | KPSS-Kao Professional Salon Services GmbH (DE) | 2010-03-10 | — | — | EP | claimed |
| EP-2161018-A1 | Cleansing composition | KPSS-Kao Professional Salon Services GmbH (DE) | 2010-03-10 | — | — | EP | claimed |
| EP-2161015-A1 | Conditioning composition for hair | KPSS-Kao Professional Salon Services GmbH (DE) | 2010-03-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210322289-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | MGLL, ADH5, GK | PRKCA 3722/4885PRKCD 2615/4885GPR84 601/4885 |
| US-10603258-B2 | Cleansing composition | KRT18, DSG1, KCNH3 | PRKCA 733/4885PRKCD 185/4885GPR84 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.